The recent disruptions in global chains have highlighted the value of securing essential medications like Ivermectin. Relying on overseas manufacturers exposes countries to potential vulnerabilities, including delivery delays, cost fluctuations, and even political concerns. Shifting towards domestic sourcing of Ivermectin offers a multitude of bene